日本語View as Markdown

Hydrogen therapy may reduce the risks related to radiation-induced oxidative stress in space flight.

宇宙飛行における放射線誘発性酸化ストレスリスクに対する水素の潜在的効果に関する仮説

other mixed routes not assessed

Abstract

Cosmic radiation poses significant health risks to astronauts by inducing DNA and lipid damage through elevated oxidative stress. Molecular hydrogen, recognized for its potent antioxidant and anti-inflammatory properties, is proposed here as a potential preventive agent against radiation-induced adverse events in space. The authors hypothesize that administering H2 via inhalation or hydrogen-rich water consumption could offer a practical and feasible approach to mitigating these risks. Given the anticipated growth in space mission frequency and duration, early intervention before clinical symptoms emerge is considered essential, and hydrogen is presented as a candidate strategy warranting further investigation.

Mechanism

H2 is proposed to selectively scavenge reactive oxygen species generated by cosmic radiation, thereby reducing oxidative damage to DNA and lipids before clinical manifestations develop.

Bibliographic

Authors
Schoenfeld MP, Ansari RR, Zakrajsek JF, Billiar TR, Toyoda Y, Wink DA, et al.
Journal
Med Hypotheses
Year
2011
PMID
20851533
DOI
10.1016/j.mehy.2010.08.046
PMC
PMC7596391

Tags

Disease:がん放射線療法 (副作用軽減) Delivery:吸入投与 水素水経口投与 Mechanism:抗酸化酵素 ヒドロキシルラジカル消去 脂質過酸化 酸化ストレス 活性酸素種

Delivery context

This study combines multiple delivery routes. As a general principle, the most efficient route for routine hydrogen intake is inhalation. Inhalation carries explosion risk (empirical LFL of 10%; high-concentration devices are documented in the Consumer Affairs Agency accident database and are not recommended).

Safety notes

This study combines multiple delivery routes. As a general principle, the most efficient route for routine hydrogen intake is inhalation. Inhalation carries explosion risk (empirical LFL of 10%; high-concentration devices are documented in the Consumer Affairs Agency accident database and are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 20851533. https://h2-papers.org/en/papers/20851533
Source: PubMed PMID 20851533